Liquidia Technologies is trading at $70.53, down 4.27%, with no clear immediate catalyst identified.
- No company-specific announcement explaining the September 29, 2026 decline surfaced in available news.
- The latest identified company release was September 3, concerning FDA Fast Track designation for YUTREPIA.
- Major indexes were nearly flat; a September 23 article discussed competition and commercial momentum but did not establish a catalyst for this session.